A six-month, prospective, multicenter, open label, parallel, randomized study of the safety, tolerability and efficacy of EC-MPS with basiliximab corticosteroids and two different levels of tacrolimus in de novo renal transplant recipients.

Trial Profile

A six-month, prospective, multicenter, open label, parallel, randomized study of the safety, tolerability and efficacy of EC-MPS with basiliximab corticosteroids and two different levels of tacrolimus in de novo renal transplant recipients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Feb 2017

At a glance

  • Drugs Mycophenolate sodium (Primary) ; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 28 Jan 2011 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
    • 23 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top